In our letter, we comment the paper of Kounis et al., that highlights a poor-known clinical entity determined by systemic use of corticosteroids, the so-called "Kounis syndrome type I". We appreciated and shared the intent of Authors to treat the important issue of high risk of adverse drug reaction in patients with atopic diathesis and we confirm the need to administer corticosteroids with caution in patients suffering from allergic disease.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323731PMC
http://dx.doi.org/10.1186/s13052-018-0600-zDOI Listing

Publication Analysis

Top Keywords

authors' reply
4
reply anaphylactic
4
anaphylactic shock
4
shock methylprednisolone
4
methylprednisolone kounis
4
kounis syndrome
4
syndrome hypersitivity
4
hypersitivity corticosteroids
4
corticosteroids clinical
4
clinical paradox
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!